ECP 2022 Abstract Book
Virchows Archiv (2022) 481 (Suppl 1):S1–S364 13 Conclusion: A new HRD solution beyond BRCA1/2 mutation detection provides expanded clinical information and improves the diagnostic yield of HRD in OC. This could be useful for personal- ized OC treatment. PS-08-029 Influence of histological and immunohistochemical features of endometrioid adenocarcinoma on the microvascular tumour density M. Lyndin*, O. Kravtsova, V. Sikora, N. Hyriavenko, Y. Lyndina, Y. Soroka, R. Moskalenko, A. Romaniuk *Sumy State University, Ukraine Background & objectives: Endometrioid adenocarcinomas of the uterine body account for about 70-80% of all endometrial carcino- mas. The most proven prognostic markers are age, stage of the disease, histological grade, microvascular density (MVD), and expression of prognostically important receptors. Methods: The investigation was conducted on 30 samples of endo- metrioid adenocarcinomas. The presence of E-cadherin, VEGF, ER, PR, Ki-67, and р53 was detected by immunohistochemistry. Results: The pronounced predominance of MVD in moderately and low-differentiated tumours over highly differentiated endometrioid adenocarcinomas was found (F=6.34, p=0.0055). A positive correlation was found between MVD and the expression of VEGF (r=0.47, p=0.0086) and Ki-67 (r=0.54, p=0.0023) in tumour cells; a negative – between MVD and PR (r=-0.45, p=0.012). Expression of ER, E-cadherin, and p53 had no effect on the MVD of neoplastic tissues (p>0.05). Conclusion: The neovascularization degree and microvascular density of endometrioid endometrial adenocarcinoma tissues are enhanced by tumour dedifferentiation and VEGF overexpression. There is a positive correlation between the proliferative activity level of tumour cells and MVD; a negative – between the expres- sion of PR and MVD. PS-08-030 Germline and somatic BRCA1 and BRCA2 mutational analy- sis in non-mucinous ovarian carcinomas. A retrospective and descriptive study of 80 cases A.B. Moreno García*, I. Costa Trachsel, C.M. Blázquez-Mañá, A. Reques Llanos, R. Carrera-Salas, M.J. Martinez Reyes, A. Falgueras i Sanchez, M.d.C. Ramos-Guijo, Y. Garcia Garcia, L. Ribot Luna, A. Ruiz Nel·lo, J.C. Ferreres Piñas *Department of Pathology. Parc Taulí Hospital Universitari. Sabadell; Institut de Recerca i Innovació Parc Taulí (I3PT), Uni- versitat Autónoma de Barcelona, Spain Background & objectives: BRCA1 and BRCA2 somatic or germline mutations in ovarian cancer (OC) have familial, prognostic and pre- dictive significance. We analysed the mutational status of these genes in our cohort of patients and its correlation with several clinical and pathological parameters. Methods: Next-generation sequencing of BRCA1 and BRCA2 was performed in 80 patients with non-mucinous OC, in tumour and peripheral blood, from January 2019: 62 high-grade serous (HGSC), 8 low-grade endometrioid, 3 high-grade endometrioid (HGECC), 4 clear cell (CCC), 1 low-grade serous carcinomas, 1 carcinosarcoma and 1 borderline serous tumour. Age, FIGO stage, histological type, clinical behaviour and molecular features were collected. Results: Twenty-five pathogenic variants(PV) in 23/79 tumour- samples (30%) were detected: 16 BRCA1/ 9 BRCA2; 15 germinal(g) (60%) and 5 (20%) somatic(s) (5 blood pending); 16 "frameshift", 5 "nonsense", 3 "missense" and 1 "splicing” (identi- cal results in germinal confirmed cases). Somatic medium allelic frequencies(AF) were 28% versus 68% in germinal cases. One addi- tional germinal (no tumour analysis available) was detected. 22 were HGSC (15 BRCA1/7 BRCA2), one CCC (gBRCA1/sBRCA2), and one HGECC (BRCA1/ BRCA2, blood pending, tumourAF 54%/70%). BRCA mutated-patients were 55.7yo-medium and 20% stage I-II, at diagnosis; non-mutated were 65.5yo and 25% I-II. All BRCA mutated-patients are alive, 40% with no disease(AWND); 12% of non-mutated-patients are exitus and 20% are AWND. Conclusion: The mutational study of BRCA1/BRCA2 in tumour- tissue is cost-effective, sensitive and specific for germinal and somatic line PV detection. Germinal, “frameshift” type and HGSC are the prevalent mutation-line, PV and histologic type, respec- tively. PV in tumour and blood in germinal confirmed cases were identical. Mutated cases are associated with younger onset age patients and better clinical behaviour, compared to non-mutated cases. This analysis is essential for an optimal management and for individual and family counselling. PS-08-033 Uterine smooth muscle tumours of uncertain malignant poten- tial (STUMPs) with fumarate hydratase deficiency: report of 2 cases C. Alves-Vale*, A. Beltran, A. Alves *CUF Descobertas Hospital, Portugal Background & objectives: Fumarate hydratase (FH) deficiency accounts for characteristic architectural and cytological features, which may result in erroneous classification of uterine neoplasms if not recognised. We report 2 cases of FH-deficient smooth muscle tumours of uncertain malignant potential (STUMPs), diagnosed after myomectomy. Methods: Case 1 refers to a 42-year-old woman presenting with a solitary uterine transmural nodule with 95 mm, without relevant personal or family history. Case 2 refers to a 27-year-old woman, with multiple uterine nodules since the age of 21 and family history of “leiomyomas”, the largest with 111 mm, refractory to ulipristal acetate therapy. Results: Microscopically, both tumours were composed of a spin- dle cell proliferation with focal areas of alveolar-type oedema and frequent vessels, sometimes with hemangiopericytoma-like pat- tern. Moderate to severe atypia was observed, including bizarre nuclei or prominent nucleoli with perinucleolar halo. Cytoplasm was eosinophilic, with rhabdoid inclusions focally. Immunore- activity for FH was lost. Mitotic index was lower than 4/mm2. Necrosis of indeterminate nature was present in the first case, and both tumour cell necrosis and ischemic-type necrosis were detected in the second. The diagnosis of FH-deficient STUMP was made. Patients were referred to the Genetics consultation to exclude FH germline mutations, associated to hereditary leiomy- omatosis and renal cell carcinoma (HLRCC) syndrome. Conclusion: It is essential to recognize the prototypical morphol- ogy of FH-deficient neoplasms, in order to avoid overdiagnosis of malignancy in uterine smooth muscle tumours, with special impact on young women who desire to preserve fertility. Although close follow- up is recommended, the majority of STUMPs have benign behav- iour. FH-deficient neoplasms may occur sporadically or associated to HLRCC syndrome, hence the importance of its prompt recognition to enable the early detection of aggressive forms of renal cell carcinoma. S114
Made with FlippingBook
RkJQdWJsaXNoZXIy Mzg2Mjgy